Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study

被引:0
|
作者
Grazia Palomba
Valentina Doneddu
Antonio Cossu
Panagiotis Paliogiannis
Antonella Manca
Milena Casula
Maria Colombino
Annamaria Lanzillo
Efisio Defraia
Antonio Pazzola
Giovanni Sanna
Carlo Putzu
Salvatore Ortu
Mario Scartozzi
Maria Teresa Ionta
Giovanni Baldino
Giuseppina Sarobba
Francesca Capelli
Tito Sedda
Luciano Virdis
Michela Barca
Giulia Gramignano
Mario Budroni
Francesco Tanda
Giuseppe Palmieri
机构
[1] CNR,Institute of Biomolecular Chemistry
[2] University of Sassari,Department of Surgical, Microsurgical and Medical Sciences
[3] Businco Hospital,Oncology Unit
[4] University—Hospital of Sassari (AOU),Medical Oncology Unit
[5] Local Health Agency,Oncology Unit
[6] University of Cagliari,Department of Medical Oncology
[7] Civil Hospital,Oncology Unit
[8] Zonchello Hospital,Oncology Unit
[9] Local Health Agency,Oncology Unit
[10] Local Health Agency,Oncology Unit
[11] Local Health Agency,Oncology Unit
关键词
Colorectal cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
    Palomba, Grazia
    Doneddu, Valentina
    Cossu, Antonio
    Paliogiannis, Panagiotis
    Manca, Antonella
    Casula, Milena
    Colombino, Maria
    Lanzillo, Annamaria
    Defraia, Efisio
    Pazzola, Antonio
    Sanna, Giovanni
    Putzu, Carlo
    Ortu, Salvatore
    Scartozzi, Mario
    Ionta, Maria Teresa
    Baldino, Giovanni
    Sarobba, Giuseppina
    Capelli, Francesca
    Sedda, Tito
    Virdis, Luciano
    Barca, Michela
    Gramignano, Giulia
    Budroni, Mario
    Tanda, Francesco
    Palmieri, Giuseppe
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [2] Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas
    Vakiani, E.
    Janackinaram, M.
    Shia, J.
    Saltz, L.
    Kemeny, N.
    Weiser, M.
    Solit, D.
    [J]. MODERN PATHOLOGY, 2011, 24 : 171A - 171A
  • [3] Analysis of KRAS, NRAS, BRAF and PIK3CA Mutations in Matched Primary and Metastatic Colorectal Carcinomas
    Vakiani, E.
    Janackinaram, M.
    Shia, J.
    Saltz, L.
    Kemeny, N.
    Weiser, M.
    Solit, D.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 171A - 171A
  • [4] Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer
    Foltran, Luisa
    De Maglio, Giovanna
    Pella, Nicoletta
    Ermacora, Paola
    Aprile, Giuseppe
    Masiero, Elena
    Giovannoni, Mariella
    Iaiza, Emiliana
    Cardellino, Giovanni Gerardo
    Lutrino, Stefania Eufemia
    Mazzer, Micol
    Giangreco, Manuela
    Pisa, Federica Edith
    Pizzolitto, Stefano
    Fasola, Gianpiero
    [J]. FUTURE ONCOLOGY, 2015, 11 (04) : 629 - 640
  • [5] Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer
    Ma, Brigette B.
    Mo, Frankie
    Tong, Joanna H.
    Wong, Ashley
    Wong, S. C. Cesar
    Ho, Wing M.
    Wu, Cherry
    Lam, Polly W. Y.
    Chan, K. F.
    Chan, Timothy S. K.
    Tsui, Wilson M. S.
    Tsang, Alex K. H.
    Fung, Mandy N. S.
    Chan, Anthony T. C.
    To, Ka Fai
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (02) : 160 - 169
  • [6] Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study
    Wojas-Krawczyk, Kamila
    Kalinka-Warzocha, Ewa
    Reszka, Katarzyna
    Nicos, Marcin
    Szumilo, Justyna
    Mandziuk, Slawomir
    Szczepaniak, Katarzyna
    Kupnicka, Dorota
    Lewandowski, Remigiusz
    Milanowski, Janusz
    Krawczyk, Pawel
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (01): : 67 - 73
  • [7] Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
    Bonetti, Luca Reggiani
    Barresi, Valeria
    Maiorana, Antonino
    Manfredini, Samantha
    Caprera, Cecilia
    Bettelli, Stefania
    [J]. DISEASE MARKERS, 2018, 2018
  • [8] Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
    Takahashi N.
    Yamada Y.
    Taniguchi H.
    Fukahori M.
    Sasaki Y.
    Shoji H.
    Honma Y.
    Iwasa S.
    Takashima A.
    Kato K.
    Hamaguchi T.
    Shimada Y.
    [J]. BMC Research Notes, 7 (1)
  • [9] Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma - occurence and prognostic significance
    Modos, Orsolya
    Reis, Henning
    Niedworok, Christian
    Ruebben, Herbert
    Szendroi, Attila
    Szasz, Marcell A.
    Timar, Jozsef
    Baghy, Kornelia
    Kovalszky, Ilona
    Golabek, Tomasz
    Chlosta, Piotr
    Okon, Krzysztof
    Peyronnet, Benoit
    Mathieu, Romain
    Shariat, Shahrokh F.
    Hollosi, Peter
    Nyirady, Peter
    Szarvas, Tibor
    [J]. ONCOTARGET, 2016, 7 (26) : 39293 - 39301
  • [10] Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond
    Katsios, Christos
    Ziogas, Dimosthenis E.
    Roukos, Dimitrios H.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) : 525 - 529